Spring Bank Pharmaceuticals, Inc.·4

May 22, 9:10 AM ET

Driscoll Martin J 4

4 · Spring Bank Pharmaceuticals, Inc. · Filed May 22, 2019

Insider Transaction Report

Form 4
Period: 2019-05-21
Driscoll Martin J
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2019-05-21$6.63/sh+5,000$33,15075,400 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION